UK invests $13M+ in 17 biopharma manufacturers
22 Aug 2023
Gene Therapy
The UK is making a £13 million investment into 17 manufacturers dotted throughout the country.
The companies do a range of work, including manufacturing nucleic acid-based medicines, automating or digitalizing manufacturing efforts, or developing methods around intracellular drug delivery for vaccines. The funds come from Innovate UK, a public entity supporting technology and science businesses.
This includes contract manufacturer Rentschler Biopharma, which plans to implement analytical technologies to boost efficiency in the production of gene therapies. Rentschler recently built a cell and gene manufacturing site in Stevenage.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.